ACCU-CHEK® Nano Diabetes Monitoring Kit
The ACCU-CHEK Nano is small, bright and fits into your life.
- With ACCU-CHEK SmartView test strips—as tested against a 23% tighter specification.1
- To fit in the palm of your hand
- Makes reading your numbers easy anytime, anywhere
- For fewer steps in testing.
- Small, 0.6 microliter sample size means less blood
- Fast, accurate results in 5 seconds
- Use with fingertip or palm testing2
- Includes simple, easy-to-use paper tools to help you lower your A1C4
- Before- and after-meal markers help you see how food affects your blood sugar, plus 4 customizable test reminders
- Downloadable 500-value memory with 7-, 14-, 30- and 90-day averaging
- Uses 2 readily available 3-volt lithium coin cell batteries
- 2.7" H x 1.7" W x 0.8" D; 1.4 oz. with batteries
- Compatible with ACCU-CHEK data management tools
- Manufactured in the U.S.A.5
Enjoy advanced accuracy with ACCU-CHEK® SmartView test strips—as tested against a 23% tighter specification.1
Easy to handle, quick-fill strip
- With a bright yellow window makes dosing easy
- Means less blood
- To help you save money on test strips,3 and covered by Medicare and Medicaid6
Reduce the pain and hassle of blood glucose testing. The ACCU-CHEK FastClix lancing device is the only 1-click lancing device with a drum of 6 preloaded lancets.
Proven least painful and overall easiest to use.4
- Precision-guided technology minimizes painful side-to-side motion and carefully manufactured, beveled 30-gauge lancets ensure smoother entry
- The Comfort Dial offers 11 customizable depth settings for different skin types
- No individual lancets to see or touch, and easy to use. Plus, the lancet lever makes it easy to advance to a new lancet and a counter shows the number of lancets remaining
2Talk with your healthcare professional before deciding if alternate site testing is right for you.
3Based on internal analysis of plans with 150,000 or more commercial pharmacy lives. Co-payments and preferred statuses vary from plan to plan.
4Polonsky WH, et al. Structured self-monitoring of blood glucose significantly reduces A1C levels in poorly controlled, noninsulin-treated type 2 diabetes: results from the Structured Testing Program study. Diabetes Care. 2011;34(2):262–267.
5Using U.S. and imported materials.
6Coverage may vary based on your condition and other factors.